VERITTI, Daniele
 Distribuzione geografica
Continente #
NA - Nord America 5.781
AS - Asia 2.685
EU - Europa 1.455
SA - Sud America 571
AF - Africa 55
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.555
Nazione #
US - Stati Uniti d'America 5.701
SG - Singapore 1.400
CN - Cina 517
BR - Brasile 482
UA - Ucraina 320
HK - Hong Kong 292
IT - Italia 282
VN - Vietnam 209
DE - Germania 206
RU - Federazione Russa 174
FI - Finlandia 105
IE - Irlanda 88
TR - Turchia 72
GB - Regno Unito 68
SE - Svezia 65
IN - India 56
CA - Canada 51
AR - Argentina 36
FR - Francia 30
KR - Corea 26
NL - Olanda 25
AT - Austria 23
BD - Bangladesh 22
ZA - Sudafrica 20
PL - Polonia 18
EC - Ecuador 17
ID - Indonesia 17
MX - Messico 17
JP - Giappone 16
BE - Belgio 15
PK - Pakistan 12
ES - Italia 9
CO - Colombia 8
PY - Paraguay 8
CL - Cile 7
IQ - Iraq 7
MA - Marocco 7
KE - Kenya 6
TG - Togo 6
UZ - Uzbekistan 6
LT - Lituania 4
OM - Oman 4
RO - Romania 4
SA - Arabia Saudita 4
VE - Venezuela 4
AL - Albania 3
AU - Australia 3
AZ - Azerbaigian 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
EG - Egitto 3
KZ - Kazakistan 3
PE - Perù 3
PT - Portogallo 3
TN - Tunisia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
CY - Cipro 2
EU - Europa 2
JO - Giordania 2
KG - Kirghizistan 2
LU - Lussemburgo 2
NP - Nepal 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DZ - Algeria 1
GE - Georgia 1
GH - Ghana 1
GL - Groenlandia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
ML - Mali 1
MR - Mauritania 1
MT - Malta 1
MY - Malesia 1
NC - Nuova Caledonia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PR - Porto Rico 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
Totale 10.553
Città #
Woodbridge 666
Fairfield 621
Ashburn 535
Singapore 486
Ann Arbor 468
Houston 435
Chandler 429
Beijing 302
Hong Kong 285
Seattle 247
Wilmington 240
Cambridge 189
Jacksonville 187
Boardman 147
Dearborn 132
Princeton 94
Dublin 88
Los Angeles 70
Izmir 68
Ho Chi Minh City 64
Udine 57
Dallas 53
Redondo Beach 49
New York 45
Buffalo 40
San Diego 39
Hanoi 36
Hefei 33
São Paulo 31
Munich 30
Ogden 28
Norwalk 26
Seoul 26
Falls Church 23
Santa Clara 22
Belluno 21
Des Moines 21
Dong Ket 20
Ottawa 20
Warsaw 18
Belo Horizonte 17
Porto Alegre 17
Brussels 15
Mumbai 15
Phoenix 15
Rio de Janeiro 15
Chicago 14
Düsseldorf 14
Frankfurt am Main 14
Grafing 14
Stockholm 13
Toronto 12
Brooklyn 11
The Dalles 10
Brasília 9
Johannesburg 9
Lappeenranta 9
Milan 9
Montreal 9
Nanjing 9
Redmond 9
Rome 9
Vienna 9
Amsterdam 8
Biên Hòa 8
Bologna 8
Chennai 8
Denver 8
Jinan 8
Nuremberg 8
Orem 8
Treviso 8
Wuhan 8
Atlanta 7
Boston 7
Guangzhou 7
Haiphong 7
Helsinki 7
Kunming 7
Lauterbourg 7
Manchester 7
Mexico City 7
Paese 7
Quito 7
Tokyo 7
Campinas 6
Council Bluffs 6
Lomé 6
London 6
Mauá 6
Nanchang 6
Naples 6
Shenzhen 6
Tashkent 6
Thái Bình 6
Trieste 6
Turku 6
Chengdu 5
Curitiba 5
Da Nang 5
Totale 6.919
Nome #
A case of CRB1-negative Coats-like retinitis pigmentosa 172
Intravitreal aflibercept for choroidal neovascularization due to age-related macular degeneration unresponsive to ranibizumab therapy 168
Advances in pharmacotherapy for wet age-related macular degeneration 165
Proliferative Diabetic Retinopathy: Treatment Update 158
Neovascular age-related macular degeneration 157
Online optical coherence tomography during subthreshold laser irradiation 152
Major ocular complications after organ transplantation 152
Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular oedema: Six-month outcomes of the UDBASA study 152
Fluocinolone acetonide for the treatment of diabetic macular edema 152
Effects of VEGF inhibition on retinal morphology, neovascular network size, and visual acuity in patients with vascularized pigment epithelium detachment because of occult choroidal neovascularization. 152
Low-concentration infracyanine green-assisted internal limiting membrane peeling in idiopathic macular pucker 25-gauge surgery 149
Bevacizumab and triamcinolone acetonide for choroidal neovascularization due to age-related macular degeneration unresponsive to antivascular endothelial growth factors 149
Optimal Keratoplasty for the Correction of Presbyopia and Hypermetropia 147
Dexamethasone implant in diabetic macular edema in real-life situations 146
Optical coherence tomography angiography findings in diabetic retinopathy 144
Author’s response 141
One-year results of aflibercept in vascularized pigment epithelium detachment due to neovascular AMD: A prospective study 141
Triple therapy for corneal neovascularization: A case report 140
New advances in retina: A report from the International Symposium on Ocular Pharmacology and Therapeutics meeting 138
Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes 138
Pharmacotherapy for treatment of retinal vein occlusion. 137
Fundus autofluorescence applications in retinal imaging 134
Early Effects of Dexamethasone Implant on Macular Morphology and Visual Function in Patients with Diabetic Macular Edema 134
Non-proliferative diabetic retinopathy 133
Intravitreal injections: a healthcare failure modes and effects analysis. 132
Selective laser trabeculoplasty 131
Triamcinolone acetonide for the treatment of diabetic macular oedema 131
Update on combination therapy in wet age-related macular degeneration 128
The effect of triamcinolone acetonide, sodium hyaluronate, and chondroitin sulfate on human endothelial cells: An in vitro study 128
Ocular complications after hand transplantation 126
Diabetic macular edema 124
Functional and morphological changes after macular pucker surgery: An optical coherence tomography and microperimetric study 124
Triple therapy for anti-vascular endothelial growth factor nonresponders in neovascular age-related macular degeneration: Impact of different photodynamic therapy parameters 123
Different antivascular endothelial growth factor treatments and regimens and their outcomes in neovascular age-related macular degeneration: A literature review 120
Drug safety evaluation of intravitreal triamcinolone acetonide 120
Posterior juxtascleral infusion of modified triamcinolone acetonide formulation for refractory diabetic macular edema: One-year follow-up 119
Macular pucker 116
Early effects of dexamethasone implant on macular morphology and visual function in patients with macular edema secondary to retinal vein occlusion. 115
Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study 115
A comparison between a white LED confocal imaging system and a conventional flash fundus camera using chromaticity analysis 114
One-year outcome of ranibizumab for neovascular age-related macular degeneration: a thorough analysis in a real-world clinical setting. 113
Pharmacotherapeutic management of macular edema in diabetic subjects undergoing cataract surgery 111
A Propensity-Score Matching Comparison between 27-Gauge and 25-Gauge Vitrectomy Systems for the Repair of Primary Rhegmatogenous Retinal Detachment 111
Intravitreal steroids for the treatment of retinal diseases. 110
Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome 109
Dexamethasone Implant Produces Better Outcomes than Oral Acetazolamide in Patients with Cystoid Macular Edema Secondary to Retinitis Pigmentosa 108
Regression of diabetic macular edema after subcutaneous exenatide. 104
Steroids in a Combination Strategy 101
Trauma and emergencies 100
Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy 100
Experience with the Pascal® photocoagulator: An analysis of over 1200 laser procedures with regard to parameter refinement 98
Ocular Findings in {COVID}-19 Patients: A Review of Direct Manifestations and Indirect Effects on the Eye 94
TWELVE-MONTH OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Fixed Versus As-needed Dosing 93
The Present and Future of Optic Pathway Glioma Therapy 90
Vascular Anomalies of the Fundus Oculi: Diagnosis and Treatment 89
Scleral fixation of a single-piece foldable acrylic IOL through a 1.80 mm corneal incision 89
Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular edema: the UDBASA study 88
null 85
Color fundus autofluorescence to determine activity of macular neovascularization in age-related macular degeneration 82
Anti-VEGF Drugs Dynamics: Relevance for Clinical Practice 82
Vitrectomy in Small idiopathic MAcuLar hoLe (SMALL) study: conventional internal limiting membrane peeling versus inverted flap 81
Intraocular pressure (IOP) after intravitreal dexamethasone implant (Ozurdex) amongst different geographic populations—GEODEX-IOP study 80
Delayed rhegmatogenous retinal detachment post macular surgery - a multicentric study 80
Combination Therapy for Choroidal Neovascularization Due to Age-Related Macular Degeneration Unresponsive to Anti-VEGF Monotherapy. Intravitreal Bevacizumab and Triamcinolone Acetonide 79
Choriocapillaris and outer choroid blood flow in acute central serous chorioretinopathy: a swept source OCT angiography study 78
Automated diabetic retinopathy detection with two different retinal imaging devices using artificial intelligence: a comparison study 78
Diabetic macular edema 77
Impact on quality of life 74
Edema maculare post occlusione venosa 73
Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers 71
Behind the mask: a critical perspective on the ethical, moral, and legal implications of AI in ophthalmology 69
Vitrectomy in Small idiopathic MAcuLar hoLe (SMALL) study: Internal limiting membrane peeling versus no peeling 68
Faricimab in Neovascular AMD Complicated by Pigment Epithelium Detachment: An AI-Assisted Evaluation of Early Morphological Changes 67
Stem cell therapy in retinal diseases: current evidence 67
Pharmacokinetic and Pharmacodynamic Rationale for Extending VEGF Inhibition Increasing Intravitreal Aflibercept Dose 65
Surgical Management for Diabetic Macular Edema 65
Occhio 65
Subthreshold laser 65
Current role of intravitreal injections in Irvine Gass syndrome-CRIIG study 64
Validation of Esaso Classification of Diabetic Maculopathy 62
The role of steroids in the treatment of diabetic macular edema 62
Managing Neovascular Age-Related Macular Degeneration in Clinical Practice: Systematic Review, Meta-Analysis, and Meta-Regression 62
Present Status of Laser Therapy: Role of Subthreshold Laser 61
null 61
Chromaticity analysis comparing a white light confocal imaging device versus a flash fundus camera 61
Explainable artificial intelligence model for the detection of geographic atrophy using colour retinal photographs 60
Twelve months outcomes of Intravitreal aflibercept for neovascular age-related macular degeneration. Fixed versus as needed dosing 55
Intravitreal Aflibercept for Choroidal Neovascularization Due to Age-Related Macular Degeneration Unresponsive to Ranibizumab Therapy 54
Managing diabetic macular edema in clinical practice: systematic review and meta-analysis of current strategies and treatment options 54
Effects of antithrombotic agents on ophthalmological outcomes, cardiovascular risk, and mortality in hypertensive patients with retinal vein occlusion: An exploratory retrospective study 54
Lens fogging comment on “Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy” 54
Management of treatment-naïve diabetic macular edema patients: Review of real-world clinical data 53
One-year efficacy of anti-vascular endothelial growth factor agents in patients with neovascular age-related macular degeneration: a meta-analysis and meta-regression 51
Macular Holes 51
Intravitreal Bevacizumab for Choroidal Neovascularization due to Pathological Myopia: Long-term Outcomes 51
Ocular complications of diabetes mellitus in a pediatric population and proposals for screening and follow-up programs 50
INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF DIFFUSE DIABETIC MACULAR EDEMA UNRESPONSIVE TO ANTI-VEGF THERAPY 50
Response to: New norms in ophthalmic surgery during the COVID-19 pandemic: A narrative review from a Malaysia tertiary eye care center 50
Screening performance of an automated image analysis software for the detection of diabetic retinopathy using a conventional fundus photography or a confocal white LED device: a comparison study 49
Long-term outcomes after intravitreal dexamethasone treatment in steroid responders 49
Totale 9.994
Categoria #
all - tutte 45.439
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.439


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021551 0 0 0 0 0 92 38 98 124 36 100 63
2021/2022655 31 41 21 18 25 39 54 34 18 119 134 121
2022/2023925 120 64 12 140 91 234 0 70 119 9 32 34
2023/2024323 66 22 6 8 40 35 13 28 45 21 2 37
2024/20252.079 37 121 111 87 39 79 138 87 230 193 322 635
2025/20262.454 375 506 403 448 582 140 0 0 0 0 0 0
Totale 10.855